ANI Pharmaceuticals reported $2.21 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 2.50 2.04 Nov/11
FY2026Q2 Jun/2026 2.21 2.03 1.80 Aug/07
FY2026Q1 Mar/2026 2.05 1.58 1.70 May/08
FY2025Q4 Dec/2025 2.33 1.97 1.63 Feb/27
FY2025Q3 Sep/2025 2.04 1.71 1.34 Nov/07




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
ANI Pharmaceuticals USD 2.21 0.16 Jun/2026
Aurora Cannabis CAD -0.13 0.51 Mar/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Heron Therapeutics USD -0.02 0.02 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Perrigo USD 0.5 0.07 Jun/2026
Sun Pharmaceuticals INR 13.11 3.61 Jun/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026